No profile data available.
BioCardia, Inc. (BCDA) is a healthcare company in the IV treatment equipment industry, based in Sunnyvale, United States, with about 17 full-time employees.
It reported revenue of $0 for fiscal year 2025, down 100.0% from fiscal year 2024, and net income of -$8.23 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $15.74 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.
BioCardia reported $0 in revenue for fiscal year 2025, down 100.0% from $58,000 in fiscal year 2024. In Q1 2026 revenue was $0.
$15.74 million as of October 9, 2026.
Listed companies of a similar size in the same industry (IV treatment equipment) include Koru Medical Systems, Inc. (KRMD), RenovoRx, Inc. (RNXT), Modular Medical, Inc. (MODD), Citius Pharmaceuticals, Inc. (CTXR).